Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Bristol signs clinical trial collaboration with PsiOxus

Executive Summary

Bristol-Myers Squibb Co. formed an alliance to test the safety, tolerability, and preliminary efficacy of a combination of its Opdivo (nivolumab) with PsiOxus Therapeutics Ltd.'s enadenotucirev in Phase I studies for multiple tumors at later stages.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)
    • Trial Collaborations

Related Companies